Close

Intra-Cellular Therapies Announces Closing of $460 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Jan 7, 2022 04:01PM
Intra-Cellular Therapies (ITCI) Prices 9.52M Share Offering at $42/sh Jan 5, 2022 06:04AM
Intra-Cellular Therapies Prices Public Offering of Common Stock Jan 4, 2022 10:05PM
Intra-Cellular Therapies (ITCI) Announces Proposed Stock Offering Jan 3, 2022 04:01PM
Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock Jan 3, 2022 04:01PM


May 5, 2021 08:00AM Intra-Cellular Therapies to Present at Two Upcoming Investor Conferences
May 14, 2020 08:00AM Intra-Cellular Therapies to Present at the 2020 RBC Capital Markets Global Healthcare Conference
May 16, 2019 08:00AM Intra-Cellular Therapies to Present at 2019 RBC Capital Markets Global Healthcare Conference
Dec 12, 2018 11:48AM Intra-Cellular Therapies (ITCI) PT Raised to $37 at RBC Capital
May 31, 2018 03:56PM RBC Positive on Biogen (BIIB) Karp Hire Amid Partnerships/M&A Potential
Apr 18, 2018 01:59PM Biogen (BIIB) Missed Out on AveXis (AVXS) But Well-Positioned for Substantial Acquisition - RBC
Feb 15, 2018 08:00AM UPDATE - Intra-Cellular Therapies to Present at RBC Capital Markets 2018 Global Healthcare Conference
Feb 8, 2018 06:30AM RBC Capital Starts Intra-Cellular Therapies (ITCI) at Outperform
Feb 7, 2018 08:00AM Intra-Cellular Therapies to Present at Upcoming Investor Conferences
Sep 20, 2016 10:32AM Allergan pays top dollar for 'stepping stones' from neurology to dermatology
Feb 16, 2016 08:00AM Intra-Cellular Therapies to Present at the 2016 RBC Capital Markets’ Healthcare Conference
Sep 28, 2015 04:05PM Intra-Cellular Therapies Announces Closing of $345 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
Sep 28, 2015 04:05PM Intra-Cellular Therapies Announces Closing of $345 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
Sep 23, 2015 06:46AM Intra-Cellular Therapies (ITCI) Prices 6.9M Common Stock Offering at $43.50/Share
Sep 22, 2015 06:40PM Intra-Cellular Therapies Prices $300 Million Public Offering of Common Stock
Sep 22, 2015 06:40PM Intra-Cellular Therapies Prices $300 Million Public Offering of Common Stock
Sep 21, 2015 04:12PM Intra-Cellular Therapies (ITCI) to Offer $300M in Common Stock
Sep 21, 2015 04:12PM Intra-Cellular Therapies (ITCI) Commences $300M Common Stock Offering
Sep 21, 2015 04:01PM Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Sep 16, 2015 08:11AM RBC Capital Comments on Intra-Cellular's (ITCI) Positive ITI-007 Phase 3 Study
Apr 14, 2015 10:45AM Notable Analyst Rating Changes 4/14: (PAY) (AEZS) (MDR) Upgraded; (AMTD) (SANM) (WWWW) Downgraded
Apr 14, 2015 06:50AM RBC Capital Starts Intra-Cellular Therapies (ITCI) at Outperform
Mar 11, 2015 04:01PM Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
Mar 11, 2015 04:01PM Intra-Cellular Therapies Announces Closing of $130 Million Public Offering Including Exercise of Underwriters' Option to Purchase Additional Shares
Mar 6, 2015 06:14AM Intra-Cellular Therapies (ITCI) Prices 4.75M Offering at $24/Share
Mar 5, 2015 09:00PM Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
Mar 5, 2015 09:00PM Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock
Mar 4, 2015 07:14AM Intra-Cellular Therapies (ITCI) to Offer 4.25M Shares
Mar 4, 2015 07:00AM Intra-Cellular Therapies Announces Proposed Public Offering of Common Stock
Feb 17, 2015 04:30PM Intra-Cellular Therapies to Present at the 2015 RBC Capital Markets' Healthcare Conference